Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1925 of 3546 entries
View as:

Promacta Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01064336 Org: User:
Start: 03/31/10 End: 07/31/14 Due: 07/31/15

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01000597 Org: User:
Start: 09/17/09 End: 12/23/09 Due: 12/23/10

WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)

Phase: N/A Priority: Normal
NCT ID: NCT01616472 Org: User:
Start: 04/30/12 End: 01/31/16 Due: 01/31/17

Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT01072162 Org: User:
Start: 01/12/10 End: 04/07/10 Due: 04/07/11

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00363857 Org: User:
Start: 08/31/03 End: 05/31/04 Due: 05/31/05

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Phase: N/A Priority: Normal
NCT ID: NCT01128621 Org: User:
Start: 11/23/09 End: 04/12/10 Due: 04/12/11

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00796445 Org: User:
Start: 12/01/08 End: 01/27/16 Due: 01/27/17

Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above

Phase: N/A Priority: Normal
NCT ID: NCT00476307 Org: User:
Start: 06/30/07 End: 07/31/07 Due: 07/31/08

A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)

Phase: N/A Priority: Normal
NCT ID: NCT00612820 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT00441116 Org: User:
Start: 12/15/06 End: 01/21/08 Due: 01/21/09

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT01738477 Org: User:
Start: 01/31/13 End: 04/02/14 Due: 04/02/15

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT01957150 Org: User:
Start: 01/28/14 End: 03/26/18 Due: 03/26/19

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints

Phase: N/A Priority: Normal
NCT ID: NCT00292552 Org: User:
Start: 12/31/05 End: 02/28/10 Due: 02/28/11

DUAC® Early Onset Efficacy Study in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02557399 Org: User:
Start: 10/07/15 End: 02/17/16 Due: 02/17/17

Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT02563899 Org: User:
Start: 11/23/15 End: 02/25/16 Due: 02/25/17

Oral Contraceptive Interaction Study for GW273225

Phase: N/A Priority: Normal
NCT ID: NCT00483535 Org: User:
Start: 03/07/07 End: 11/16/07 Due: 11/16/08

Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)

Phase: N/A Priority: Normal
NCT ID: NCT03501420 Org: User:
Start: 06/13/18 End: 10/30/18 Due: 10/30/19

Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00725764 Org: User:
Start: 08/27/07 End: 05/02/09 Due: 05/02/10

GSK1247303 First Time in Human Study

Phase: N/A Priority: Normal
NCT ID: NCT00651079 Org: User:
Start: 02/29/08 End: 05/31/08 Due: 05/31/09

AED/Statin Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00627575 Org: User:
Start: 02/04/08 End: 09/12/08 Due: 09/12/09

GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir

Phase: N/A Priority: Normal
NCT ID: NCT00883935 Org: User:
Start: 04/30/09 End: 06/30/09 Due: 06/30/10

A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.

Phase: N/A Priority: Normal
NCT ID: NCT00396630 Org: User:
Start: 01/23/07 End: 02/13/08 Due: 02/13/09

Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT01119625 Org: User:
Start: 07/12/10 End: 02/17/11 Due: 02/17/12

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT01607112 Org: User:
Start: 07/10/12 End: 07/31/12 Due: 07/31/13

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00697853 Org: User:
Start: 11/30/98 End: - Due: -